Thymosin for injection

Pharmacodynamics: This product is an immunomodulatory drug. It has the function of regulating and enhancing the cellular immune function of the human body and can promote the maturation of T-lymphocytes.

Thymosin α1 and other small peptides

It is used to treat various primary or secondary T-cell deficiency diseases, certain autoimmune diseases, various diseases with low cellular immune function and as an adjuvant therapy for tumors. Including: 1. Various types of severe hepatitis, chronic active hepatitis, chronic persistent hepatitis and cirrhosis; 2. Herpes zoster, genital herpes, condyloma acuminatum; 3. Prevention of upper respiratory tract infection in bronchitis, bronchial asthma, tuberculosis; 4. Pre-stage of various malignant tumors and chemotherapy, combined with radiotherapy; 5. Lupus erythematosus, rheumatic and rheumatoid diseases, ankylosing spondylitis, Guillain-Barré syndrome; 6. Aplastic anemia, leukemia, thrombocytopenia; 7. Viral keratitis, viral conjunctivitis, allergic rhinitis; 8. Premature aging of the elderly, menopausal syndrome in women; 9. Multiple furunculosis and facial skin acne, psoriasis, lichen planus, squamous cell carcinoma and epithelial keratosis; 10. Congenital immunodeficiency in children.

Subcutaneous or intramuscular injection: 10-20 mg once a day or as directed by a physician. Intravenous drip: 20-80 mg once, dissolved in 500 ml of 0.9% sodium chloride injection or 5% glucose injection, once a day or as directed by a physician.

Not yet clear.

Those with positive reaction should not use it.

Not yet clear.

Keep tightly closed in a cool, dark place.

20 mg